Altered systemic cortisol metabolism in bipolar disorder and schizophrenia spectrum disorders

Abstract Dysfunction of the hypothalamic-pituitary-adrenal (HPA) axis is suggested as a pathophysiological factor in bipolar disorder and schizophrenia. Increased clearance of cortisol was recently indicated as a component in the HPA axis hyperdrive. The aim of the present study was to test the mode...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of psychiatric research 2014-05, Vol.52, p.57-62
Hauptverfasser: Steen, Nils Eiel, Methlie, Paal, Lorentzen, Steinar, Dieset, Ingrid, Aas, Monica, Nerhus, Mari, Haram, Marit, Agartz, Ingrid, Melle, Ingrid, Berg, Jens P, Andreassen, Ole A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 62
container_issue
container_start_page 57
container_title Journal of psychiatric research
container_volume 52
creator Steen, Nils Eiel
Methlie, Paal
Lorentzen, Steinar
Dieset, Ingrid
Aas, Monica
Nerhus, Mari
Haram, Marit
Agartz, Ingrid
Melle, Ingrid
Berg, Jens P
Andreassen, Ole A
description Abstract Dysfunction of the hypothalamic-pituitary-adrenal (HPA) axis is suggested as a pathophysiological factor in bipolar disorder and schizophrenia. Increased clearance of cortisol was recently indicated as a component in the HPA axis hyperdrive. The aim of the present study was to test the model of increased cortisol metabolism in a new replication sample separately and combined with a previously published sample of bipolar disorder and schizophrenia. Spot urine was sampled from 212 healthy controls (HC) and 221 patients with a schizophrenia spectrum disorder (SCZ, n  = 115) and bipolar disorder (BD, n  = 106). Of these, a subsample of 169 HC and 155 patients was included in a previous report. Urinary free cortisol, cortisone and their metabolites were measured, and the activities of 5α-reductase, 5β-reductase and 11β-HSD were estimated and analyzed for differences between groups. In the new sample, there was increased enzyme activity in SCZ for 5β-reductase ( p  = 0.024 vs HC; p  = 0.027 vs BD) and 11β-HSD2 ( p  = 0.014 vs HC; p  = 0.004 vs BD). In the combined sample, there was increased activity in SCZ for 5α-reductase ( p  
doi_str_mv 10.1016/j.jpsychires.2014.01.017
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1541985705</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0022395614000260</els_id><sourcerecordid>1520381926</sourcerecordid><originalsourceid>FETCH-LOGICAL-c558t-5e68ec716683d35eae0e5c26dbc5b626953189aef11ee3e9ee73bfdd924d6c8e3</originalsourceid><addsrcrecordid>eNqNkk2LFDEQhhtR3NnVvyB9EbzMmEo6XxdhXXQVFjyoRwnppIbN2F-muoXx15thxl3wNFCQQ563qqj3raoa2AYYqLe7zW6ifbhPGWnDGTQbBqX0k2oFRts1CG2fVivGOF8LK9VFdUm0Y4xpDs3z6oI3UjQKzKr6cd3NmDHWtKcZ-xTqMOY50djVPc6-HbtEfZ2Guk3T2Plcx_KXI-baD0VUVvgzTvcZh-RrmjDMeekfGHpRPdv6jvDl6b2qvn_88O3m0_ruy-3nm-u7dZDSzGuJymDQoJQRUUj0yFAGrmIbZKu4slKAsR63AIgCLaIW7TZGy5uogkFxVb059p3y-GtBml2fKGDX-QHHhRzIBqyRmskzUNEY0QAzZ6CcCQOWqzNQprW1WoqCmiMa8kiUceumnHqf9w6YO7jrdu7RXXdw1zEopYv01WnK0vYYH4T_7CzA6xPgKfhum_0QEj1yRjBVrlC490cOiym_E2ZHIeEQMJaZYXZxTOds8-6_JqFLQypzf-IeaTcueSimO3DEHXNfD2k8hBGaEkSumPgLAiLeGg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1507799753</pqid></control><display><type>article</type><title>Altered systemic cortisol metabolism in bipolar disorder and schizophrenia spectrum disorders</title><source>Applied Social Sciences Index &amp; Abstracts (ASSIA)</source><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Steen, Nils Eiel ; Methlie, Paal ; Lorentzen, Steinar ; Dieset, Ingrid ; Aas, Monica ; Nerhus, Mari ; Haram, Marit ; Agartz, Ingrid ; Melle, Ingrid ; Berg, Jens P ; Andreassen, Ole A</creator><creatorcontrib>Steen, Nils Eiel ; Methlie, Paal ; Lorentzen, Steinar ; Dieset, Ingrid ; Aas, Monica ; Nerhus, Mari ; Haram, Marit ; Agartz, Ingrid ; Melle, Ingrid ; Berg, Jens P ; Andreassen, Ole A</creatorcontrib><description>Abstract Dysfunction of the hypothalamic-pituitary-adrenal (HPA) axis is suggested as a pathophysiological factor in bipolar disorder and schizophrenia. Increased clearance of cortisol was recently indicated as a component in the HPA axis hyperdrive. The aim of the present study was to test the model of increased cortisol metabolism in a new replication sample separately and combined with a previously published sample of bipolar disorder and schizophrenia. Spot urine was sampled from 212 healthy controls (HC) and 221 patients with a schizophrenia spectrum disorder (SCZ, n  = 115) and bipolar disorder (BD, n  = 106). Of these, a subsample of 169 HC and 155 patients was included in a previous report. Urinary free cortisol, cortisone and their metabolites were measured, and the activities of 5α-reductase, 5β-reductase and 11β-HSD were estimated and analyzed for differences between groups. In the new sample, there was increased enzyme activity in SCZ for 5β-reductase ( p  = 0.024 vs HC; p  = 0.027 vs BD) and 11β-HSD2 ( p  = 0.014 vs HC; p  = 0.004 vs BD). In the combined sample, there was increased activity in SCZ for 5α-reductase ( p  &lt; 0.001 vs HC; p  = 0.020 vs BD), 5β-reductase ( p  &lt; 0.001 vs HC; p  = 0.045 vs BD) and 11β-HSD2 ( p  &lt; 0.001 vs HC; p  = 0.043 vs BD), and in BD for 5β-reductase ( p  = 0.002), 11β-HSD2 ( p  = 0.039) and 5α-reductase (trend, p  = 0.084) (all vs HC). The findings confirm increased systemic cortisol metabolism in BD and SCZ. This is most consistent in SCZ, with BD taking an intermediate position. The design makes it impossible to determine the direction of the effect. However, the findings merit further study of cortisol metabolism as a possible component in the HPA axis dysfunction and pathophysiology of BD and SCZ.</description><identifier>ISSN: 0022-3956</identifier><identifier>EISSN: 1879-1379</identifier><identifier>DOI: 10.1016/j.jpsychires.2014.01.017</identifier><identifier>PMID: 24534618</identifier><identifier>CODEN: JPYRA3</identifier><language>eng</language><publisher>Kidlington: Elsevier Ltd</publisher><subject>11β-Hydroxysteroid dehydrogenase ; 5α reductase ; 5β reductase ; Adolescent ; Adult ; Adult and adolescent clinical studies ; Analysis of Variance ; Biological and medical sciences ; Bipolar affective disorder ; Bipolar Disorder - metabolism ; Bipolar disorders ; Cortisol ; Dysfunction ; Female ; General aspects ; Humans ; Hydrocortisone - metabolism ; Hypothalamic-pituitary-adrenal-axis ; Male ; Medical sciences ; Metabolism ; Middle Aged ; Miscellaneous ; Mood disorders ; Psychiatric Status Rating Scales ; Psychiatry ; Psychology. Psychoanalysis. Psychiatry ; Psychopathology. Psychiatry ; Psychoses ; Psychosis ; Schizophrenia ; Schizophrenia - metabolism ; Severe mental disorders ; Tetrahydrocortisol - analogs &amp; derivatives ; Tetrahydrocortisol - metabolism ; Tetrahydrocortisone - metabolism ; Urine tests ; Young Adult</subject><ispartof>Journal of psychiatric research, 2014-05, Vol.52, p.57-62</ispartof><rights>Elsevier Ltd</rights><rights>2014 Elsevier Ltd</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2014 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c558t-5e68ec716683d35eae0e5c26dbc5b626953189aef11ee3e9ee73bfdd924d6c8e3</citedby><cites>FETCH-LOGICAL-c558t-5e68ec716683d35eae0e5c26dbc5b626953189aef11ee3e9ee73bfdd924d6c8e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jpsychires.2014.01.017$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>315,782,786,3554,27933,27934,31009,46004</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=28306570$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24534618$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Steen, Nils Eiel</creatorcontrib><creatorcontrib>Methlie, Paal</creatorcontrib><creatorcontrib>Lorentzen, Steinar</creatorcontrib><creatorcontrib>Dieset, Ingrid</creatorcontrib><creatorcontrib>Aas, Monica</creatorcontrib><creatorcontrib>Nerhus, Mari</creatorcontrib><creatorcontrib>Haram, Marit</creatorcontrib><creatorcontrib>Agartz, Ingrid</creatorcontrib><creatorcontrib>Melle, Ingrid</creatorcontrib><creatorcontrib>Berg, Jens P</creatorcontrib><creatorcontrib>Andreassen, Ole A</creatorcontrib><title>Altered systemic cortisol metabolism in bipolar disorder and schizophrenia spectrum disorders</title><title>Journal of psychiatric research</title><addtitle>J Psychiatr Res</addtitle><description>Abstract Dysfunction of the hypothalamic-pituitary-adrenal (HPA) axis is suggested as a pathophysiological factor in bipolar disorder and schizophrenia. Increased clearance of cortisol was recently indicated as a component in the HPA axis hyperdrive. The aim of the present study was to test the model of increased cortisol metabolism in a new replication sample separately and combined with a previously published sample of bipolar disorder and schizophrenia. Spot urine was sampled from 212 healthy controls (HC) and 221 patients with a schizophrenia spectrum disorder (SCZ, n  = 115) and bipolar disorder (BD, n  = 106). Of these, a subsample of 169 HC and 155 patients was included in a previous report. Urinary free cortisol, cortisone and their metabolites were measured, and the activities of 5α-reductase, 5β-reductase and 11β-HSD were estimated and analyzed for differences between groups. In the new sample, there was increased enzyme activity in SCZ for 5β-reductase ( p  = 0.024 vs HC; p  = 0.027 vs BD) and 11β-HSD2 ( p  = 0.014 vs HC; p  = 0.004 vs BD). In the combined sample, there was increased activity in SCZ for 5α-reductase ( p  &lt; 0.001 vs HC; p  = 0.020 vs BD), 5β-reductase ( p  &lt; 0.001 vs HC; p  = 0.045 vs BD) and 11β-HSD2 ( p  &lt; 0.001 vs HC; p  = 0.043 vs BD), and in BD for 5β-reductase ( p  = 0.002), 11β-HSD2 ( p  = 0.039) and 5α-reductase (trend, p  = 0.084) (all vs HC). The findings confirm increased systemic cortisol metabolism in BD and SCZ. This is most consistent in SCZ, with BD taking an intermediate position. The design makes it impossible to determine the direction of the effect. However, the findings merit further study of cortisol metabolism as a possible component in the HPA axis dysfunction and pathophysiology of BD and SCZ.</description><subject>11β-Hydroxysteroid dehydrogenase</subject><subject>5α reductase</subject><subject>5β reductase</subject><subject>Adolescent</subject><subject>Adult</subject><subject>Adult and adolescent clinical studies</subject><subject>Analysis of Variance</subject><subject>Biological and medical sciences</subject><subject>Bipolar affective disorder</subject><subject>Bipolar Disorder - metabolism</subject><subject>Bipolar disorders</subject><subject>Cortisol</subject><subject>Dysfunction</subject><subject>Female</subject><subject>General aspects</subject><subject>Humans</subject><subject>Hydrocortisone - metabolism</subject><subject>Hypothalamic-pituitary-adrenal-axis</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Metabolism</subject><subject>Middle Aged</subject><subject>Miscellaneous</subject><subject>Mood disorders</subject><subject>Psychiatric Status Rating Scales</subject><subject>Psychiatry</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychopathology. Psychiatry</subject><subject>Psychoses</subject><subject>Psychosis</subject><subject>Schizophrenia</subject><subject>Schizophrenia - metabolism</subject><subject>Severe mental disorders</subject><subject>Tetrahydrocortisol - analogs &amp; derivatives</subject><subject>Tetrahydrocortisol - metabolism</subject><subject>Tetrahydrocortisone - metabolism</subject><subject>Urine tests</subject><subject>Young Adult</subject><issn>0022-3956</issn><issn>1879-1379</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>7QJ</sourceid><recordid>eNqNkk2LFDEQhhtR3NnVvyB9EbzMmEo6XxdhXXQVFjyoRwnppIbN2F-muoXx15thxl3wNFCQQ563qqj3raoa2AYYqLe7zW6ifbhPGWnDGTQbBqX0k2oFRts1CG2fVivGOF8LK9VFdUm0Y4xpDs3z6oI3UjQKzKr6cd3NmDHWtKcZ-xTqMOY50djVPc6-HbtEfZ2Guk3T2Plcx_KXI-baD0VUVvgzTvcZh-RrmjDMeekfGHpRPdv6jvDl6b2qvn_88O3m0_ruy-3nm-u7dZDSzGuJymDQoJQRUUj0yFAGrmIbZKu4slKAsR63AIgCLaIW7TZGy5uogkFxVb059p3y-GtBml2fKGDX-QHHhRzIBqyRmskzUNEY0QAzZ6CcCQOWqzNQprW1WoqCmiMa8kiUceumnHqf9w6YO7jrdu7RXXdw1zEopYv01WnK0vYYH4T_7CzA6xPgKfhum_0QEj1yRjBVrlC490cOiym_E2ZHIeEQMJaZYXZxTOds8-6_JqFLQypzf-IeaTcueSimO3DEHXNfD2k8hBGaEkSumPgLAiLeGg</recordid><startdate>20140501</startdate><enddate>20140501</enddate><creator>Steen, Nils Eiel</creator><creator>Methlie, Paal</creator><creator>Lorentzen, Steinar</creator><creator>Dieset, Ingrid</creator><creator>Aas, Monica</creator><creator>Nerhus, Mari</creator><creator>Haram, Marit</creator><creator>Agartz, Ingrid</creator><creator>Melle, Ingrid</creator><creator>Berg, Jens P</creator><creator>Andreassen, Ole A</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7TK</scope><scope>7QJ</scope></search><sort><creationdate>20140501</creationdate><title>Altered systemic cortisol metabolism in bipolar disorder and schizophrenia spectrum disorders</title><author>Steen, Nils Eiel ; Methlie, Paal ; Lorentzen, Steinar ; Dieset, Ingrid ; Aas, Monica ; Nerhus, Mari ; Haram, Marit ; Agartz, Ingrid ; Melle, Ingrid ; Berg, Jens P ; Andreassen, Ole A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c558t-5e68ec716683d35eae0e5c26dbc5b626953189aef11ee3e9ee73bfdd924d6c8e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>11β-Hydroxysteroid dehydrogenase</topic><topic>5α reductase</topic><topic>5β reductase</topic><topic>Adolescent</topic><topic>Adult</topic><topic>Adult and adolescent clinical studies</topic><topic>Analysis of Variance</topic><topic>Biological and medical sciences</topic><topic>Bipolar affective disorder</topic><topic>Bipolar Disorder - metabolism</topic><topic>Bipolar disorders</topic><topic>Cortisol</topic><topic>Dysfunction</topic><topic>Female</topic><topic>General aspects</topic><topic>Humans</topic><topic>Hydrocortisone - metabolism</topic><topic>Hypothalamic-pituitary-adrenal-axis</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Metabolism</topic><topic>Middle Aged</topic><topic>Miscellaneous</topic><topic>Mood disorders</topic><topic>Psychiatric Status Rating Scales</topic><topic>Psychiatry</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychopathology. Psychiatry</topic><topic>Psychoses</topic><topic>Psychosis</topic><topic>Schizophrenia</topic><topic>Schizophrenia - metabolism</topic><topic>Severe mental disorders</topic><topic>Tetrahydrocortisol - analogs &amp; derivatives</topic><topic>Tetrahydrocortisol - metabolism</topic><topic>Tetrahydrocortisone - metabolism</topic><topic>Urine tests</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Steen, Nils Eiel</creatorcontrib><creatorcontrib>Methlie, Paal</creatorcontrib><creatorcontrib>Lorentzen, Steinar</creatorcontrib><creatorcontrib>Dieset, Ingrid</creatorcontrib><creatorcontrib>Aas, Monica</creatorcontrib><creatorcontrib>Nerhus, Mari</creatorcontrib><creatorcontrib>Haram, Marit</creatorcontrib><creatorcontrib>Agartz, Ingrid</creatorcontrib><creatorcontrib>Melle, Ingrid</creatorcontrib><creatorcontrib>Berg, Jens P</creatorcontrib><creatorcontrib>Andreassen, Ole A</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Neurosciences Abstracts</collection><collection>Applied Social Sciences Index &amp; Abstracts (ASSIA)</collection><jtitle>Journal of psychiatric research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Steen, Nils Eiel</au><au>Methlie, Paal</au><au>Lorentzen, Steinar</au><au>Dieset, Ingrid</au><au>Aas, Monica</au><au>Nerhus, Mari</au><au>Haram, Marit</au><au>Agartz, Ingrid</au><au>Melle, Ingrid</au><au>Berg, Jens P</au><au>Andreassen, Ole A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Altered systemic cortisol metabolism in bipolar disorder and schizophrenia spectrum disorders</atitle><jtitle>Journal of psychiatric research</jtitle><addtitle>J Psychiatr Res</addtitle><date>2014-05-01</date><risdate>2014</risdate><volume>52</volume><spage>57</spage><epage>62</epage><pages>57-62</pages><issn>0022-3956</issn><eissn>1879-1379</eissn><coden>JPYRA3</coden><abstract>Abstract Dysfunction of the hypothalamic-pituitary-adrenal (HPA) axis is suggested as a pathophysiological factor in bipolar disorder and schizophrenia. Increased clearance of cortisol was recently indicated as a component in the HPA axis hyperdrive. The aim of the present study was to test the model of increased cortisol metabolism in a new replication sample separately and combined with a previously published sample of bipolar disorder and schizophrenia. Spot urine was sampled from 212 healthy controls (HC) and 221 patients with a schizophrenia spectrum disorder (SCZ, n  = 115) and bipolar disorder (BD, n  = 106). Of these, a subsample of 169 HC and 155 patients was included in a previous report. Urinary free cortisol, cortisone and their metabolites were measured, and the activities of 5α-reductase, 5β-reductase and 11β-HSD were estimated and analyzed for differences between groups. In the new sample, there was increased enzyme activity in SCZ for 5β-reductase ( p  = 0.024 vs HC; p  = 0.027 vs BD) and 11β-HSD2 ( p  = 0.014 vs HC; p  = 0.004 vs BD). In the combined sample, there was increased activity in SCZ for 5α-reductase ( p  &lt; 0.001 vs HC; p  = 0.020 vs BD), 5β-reductase ( p  &lt; 0.001 vs HC; p  = 0.045 vs BD) and 11β-HSD2 ( p  &lt; 0.001 vs HC; p  = 0.043 vs BD), and in BD for 5β-reductase ( p  = 0.002), 11β-HSD2 ( p  = 0.039) and 5α-reductase (trend, p  = 0.084) (all vs HC). The findings confirm increased systemic cortisol metabolism in BD and SCZ. This is most consistent in SCZ, with BD taking an intermediate position. The design makes it impossible to determine the direction of the effect. However, the findings merit further study of cortisol metabolism as a possible component in the HPA axis dysfunction and pathophysiology of BD and SCZ.</abstract><cop>Kidlington</cop><pub>Elsevier Ltd</pub><pmid>24534618</pmid><doi>10.1016/j.jpsychires.2014.01.017</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-3956
ispartof Journal of psychiatric research, 2014-05, Vol.52, p.57-62
issn 0022-3956
1879-1379
language eng
recordid cdi_proquest_miscellaneous_1541985705
source Applied Social Sciences Index & Abstracts (ASSIA); MEDLINE; Access via ScienceDirect (Elsevier)
subjects 11β-Hydroxysteroid dehydrogenase
5α reductase
5β reductase
Adolescent
Adult
Adult and adolescent clinical studies
Analysis of Variance
Biological and medical sciences
Bipolar affective disorder
Bipolar Disorder - metabolism
Bipolar disorders
Cortisol
Dysfunction
Female
General aspects
Humans
Hydrocortisone - metabolism
Hypothalamic-pituitary-adrenal-axis
Male
Medical sciences
Metabolism
Middle Aged
Miscellaneous
Mood disorders
Psychiatric Status Rating Scales
Psychiatry
Psychology. Psychoanalysis. Psychiatry
Psychopathology. Psychiatry
Psychoses
Psychosis
Schizophrenia
Schizophrenia - metabolism
Severe mental disorders
Tetrahydrocortisol - analogs & derivatives
Tetrahydrocortisol - metabolism
Tetrahydrocortisone - metabolism
Urine tests
Young Adult
title Altered systemic cortisol metabolism in bipolar disorder and schizophrenia spectrum disorders
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-01T05%3A36%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Altered%20systemic%20cortisol%20metabolism%20in%20bipolar%20disorder%20and%20schizophrenia%20spectrum%20disorders&rft.jtitle=Journal%20of%20psychiatric%20research&rft.au=Steen,%20Nils%20Eiel&rft.date=2014-05-01&rft.volume=52&rft.spage=57&rft.epage=62&rft.pages=57-62&rft.issn=0022-3956&rft.eissn=1879-1379&rft.coden=JPYRA3&rft_id=info:doi/10.1016/j.jpsychires.2014.01.017&rft_dat=%3Cproquest_cross%3E1520381926%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1507799753&rft_id=info:pmid/24534618&rft_els_id=1_s2_0_S0022395614000260&rfr_iscdi=true